Next Article in Journal
Nanomedicine Faces Barriers
Next Article in Special Issue
A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ9-Tetrahydrocannabinol
Previous Article in Journal
Anti-Viral Drugs for Human Adenoviruses
Previous Article in Special Issue
Cannabinoids and Reproduction: A Lasting and Intriguing History
Open AccessReview

Inactivation of Anandamide Signaling: A Continuing Debate

School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, Scotland, UK
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(11), 3355-3370;
Received: 25 August 2010 / Revised: 9 October 2010 / Accepted: 25 October 2010 / Published: 28 October 2010
(This article belongs to the Special Issue Cannabinoids)
Since the first endocannabinoid anandamide was identified in 1992, extensive research has been conducted to characterize the elements of the tightly controlled endocannabinoid signaling system. While it was established that the activity of endocannabinoids are terminated by a two-step process that includes cellular uptake and degradation, there is still a continuing debate about the mechanistic role of these processes in inactivating anandamide signals. View Full-Text
Keywords: endocannabinoid inactivation; anandamide; ethanolamine endocannabinoid inactivation; anandamide; ethanolamine
Show Figures

Figure 1

MDPI and ACS Style

Khairy, H.; Houssen, W.E. Inactivation of Anandamide Signaling: A Continuing Debate. Pharmaceuticals 2010, 3, 3355-3370.

AMA Style

Khairy H, Houssen WE. Inactivation of Anandamide Signaling: A Continuing Debate. Pharmaceuticals. 2010; 3(11):3355-3370.

Chicago/Turabian Style

Khairy, Hesham; Houssen, Wael E. 2010. "Inactivation of Anandamide Signaling: A Continuing Debate" Pharmaceuticals 3, no. 11: 3355-3370.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop